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http://dx.doi.org/10.1016/j.jds.2012.0Abstract Small-cell carcinomas at extrapulmonary primary sites are rare but they have been
documented to arise at various locations. We report a case of small-cell carcinoma arising in
the mandible, which has so far not been reported in the literature. A 37-year-old male patient
underwent partial resection of the left mandible and adjuvant chemotherapy. Immunohisto-
chemistry confirmed the diagnosis of small-cell carcinoma with neuroendocrine properties.
The patient has been free of disease for 18 months after receiving treatment and was alive
at the time of writing. We recommend surgical resection followed by chemotherapy for
managing small-cell carcinomas in the mandibular region.
Copyright ª 2012, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. All rights reserved.Introduction
Small-cell carcinomas (SmCCs) are anaplastic, highly
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SmCCs rarely originate in the head and neck region.
Survival differs between locations. The median survival
time is 8 months for SmCCs of the renal pelvis,2 whereas the
5-year survival rate for primary submandibular gland SmCCs
is 40%.3 These malignant tumors are composed of undif-
ferentiated small cells and exhibit neuroendocrine differ-
entiation by immunohistochemistry. The purpose of this
report was to present a single, rare case of SmCC that
originated from the mandible with neuroendocrine prop-
erties, based on immunohistochemistry, and describe
a viable treatment option.arcinoma with neuroendocrine properties of the mandible: A case
//dx.doi.org/10.1016/j.jds.2012.03.020
public of China. Published by Elsevier Taiwan LLC. All rights reserved.
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A 37-year-old man was admitted with a complaint of pain in
the left lower posterior teeth for 2 months and numbness in
the left lower lip for 20 days. The patient denied a history
of tobacco smoking, and his medical history was noncon-
tributory. His chest X-ray showed no signs of space-
occupying lesions in the lungs and no findings suggestive
of pulmonary neoplasia. Clinical examination showed
a tender, unmovable swelling on the mandible, numbness
of the skin of the left lower lip, and no palpable lymph
nodes in the bilateral submandibular region. Intraoral
examination showed a 2 cm  2 cm tender mass on the
buccal side of the left molar region. The teeth involved
were firm with no dislocation, and the overlying mucosa
was normal.
A panoramic radiograph revealed that an ill-defined
radiolucency of about 1 cm  1.5 cm in diameter was
involved in the root apex of the left lower first molar, and
the lesion exhibited invasive characteristics of root
resorption and periodontal ligament space widening
(Fig. 1A). A computed tomography scan showed bone
resorption of the buccal mandible body from D3 to D6
(Fig. 1B).
Laboratory data were within normal ranges. Tumor
markers including a-fetoprotein, carcinoembryonic
antigen, total prostate-specific antigen, carbohydrate
antigen 19-9, and carbohydrate antigen 125 were tested.
The examination results suggested a primary malignancy
of the mandible (cT1cN0cM0). During the operation,
a frozen biopsy was performed, which demonstrated
multiple small round cells exhibiting atypia consistent with
a malignant neoplasm. Then, partial resection of the left
mandible was performed. The continuity defect of the
mandible from the midline to the third molar was recon-
structed using a vascularized free fibular flap. The healing
process was uneventful. The patient received adjuvantFigure 1 (A) Panoramic radiograph showing ill-defined radiolu
resorption, and periodontal ligament space widening. (B) Preoperat
to D6. (C) Panoramic radiograph 18 months after surgery showing no
(D) Computed tomography scan 18 months after the patient under
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etoposide (130 mg/m2). Regular and aggressive follow-up
every 1e3 months was carried out. No evidence of local
recurrence or metastasis was observed 18 months after
treatment (Fig. 1C and D). After surgery, the chewing of
food and speech intelligibility were partially affected,
whereas tongue mobility, swallowing, and breathing were
normal.
On gross observation, the excised biopsy sample
measured 3 cm  2.5 cm, was hard, and appeared grayish-
white. The pathological characteristics of the surgical
sample revealed many scattered small foci of tumor cells
with a cicatrized fibrous stroma in the musculoadipose
tissue (Fig. 2). Therefore, an undifferentiated small-cell
malignant tumor of the mandible was diagnosed. Assess-
ment of the surgical margins showed that all margins of the
tumor were negative. No tumor was found in any of the
resected regional lymph nodes. The pathological stage was
pT2N0M0 (margin negative) according to the pathological
examination.
Subsequent immunohistochemistry demonstrated posi-
tive staining for cytokeratins AE1/AE3, CD56, synaptophy-
sin, chromogranin A, and glial fibrillary acidic protein
(Fig. 3AeC), and negative staining for myogenic differen-
tiation 1, epithelial membrane antigen, S-100 protein, CD3,
CD20, CD43, CD79a, CD99, leukocyte common antigen
(CD45), B-cell lymphoma 2 (BcL-2), human melanin black
(HMB)-45, melan-A, myeloperoxidase, and thyroid tran-
scription factor (TTF)-1 immunostaining (Fig. 4).Discussion
SmCCs are anaplastic, highly malignant, and usually bron-
chogenic carcinomas that account for 14% of bronchogenic
carcinomas.4 Extrapulmonary sites account for only 4% of
all SmCCs.1 SmCCs rarely originate in the head and neckcency of the left mandible involving the apex of D6, root
ive computed tomography scan showing a bone defect from D3
absorption on either end of the fibular graft and good healing.
went surgery and adjuvant chemotherapy.
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Figure 2 Scattered small foci of tumor cells with a cicatrized
fibrous stroma in the musculoadipose tissue (hematoxylin and
eosin, 40).
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sinus, cervical esophagus, proximal trachea, and oral cavity
are locations in the head and neck from which an SmCC may
arise.3 To the best of our knowledge, there is no report in
the literature of an SmCC primarily localized in the
mandible. There is a low incidence of jaw metastasis,
which is thought to be because the jaw has less cancellous
bone than other bones.5 The premolaremolar region is the
most common site of localization, due to a predominance
of red bone marrow and retardation of the circulation in
this area.6 Although the occurrence of an SmCC in the jawFigure 3 Immunohistochemistry staining positive for (A) glial fibri
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first considered in our case, but the possibility that the
current tumor was a metastatic SmCC arising from the lung
was excluded because no space-occupying lesion was found
on chest X-ray examination. However, the possibility that
this might represent a metastatic lesion from a small occult
primary source of <2 cm in size was excluded only after
immunohistochemical analysis.
Immunohistochemistry is a very important and the most
significant tool in differentiating between small round cell
tumors with different histogenetic origins. Positive staining
for cytokeratins (AE1/AE3) confirmed that the tumor was
epithelial in nature. Chromogranins are metrical proteins
that are associated with neurosecretory granules and are
absolutely specific for neuroendocrine differentiation.7
Synaptophysin is associated with presynaptic nerve cell
vesicles. Neuron-specific enolase is used as a screening
agent for its low specificity and sensitivity for neuroendo-
crine tumors. Other markers expressed in neuroendocrine
tumors of the head and neck are anticytokarin (CAM 5.2),
epithelial membrane antigen, carcinoembryonic antigen,
calcitonin, and S-100 protein. Negative staining with
leukocyte common antigen and HMB-45 can exclude
a diagnosis of malignant lymphoma and melanoma. The
pattern of immunostaining in this case led to a diagnosis of
SmCC with neuroendocrine properties. TTF-1 is normally
expressed only in thyroid and lung cells. For SmCCs of
various extrapulmonary sites, TTF-1 staining is usually
positive (50%), whereas for small-cell lung carcinoma, TTF-
1 staining is 90% positive. The negative TTF-1 staining in this
case essentially ruled out metastatic lung cancer.
Small-cell tumors of the bone are a heterogeneous group
of neoplasms that share overlapping clinical, radiological,llary acidic protein, (B) chromogranin A, and (C) synaptophysin.
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Figure 4 Negative immunohistochemical staining for thyroid
transcription factor-1.
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cell osteosarcomas resemble Ewing sarcomas or conven-
tional osteosarcomas radiologically. The presence of
mineralized matrix in imaging studies supports a diagnosis
of an osteosarcoma and is helpful in differentiating other
small-cell tumors of the bone. In our case, this was ruled
out by the absence of osteoids. Chondroid foci are stained
for S100 protein, and primitive mesenchymal cells are
positive for CD99. Therefore, both S100 and CD99 being
negative ruled out a mesenchymal chondrosarcoma.
Neuroblastomas can present as bone metastases and can be
distinguished from other primary round-cell tumors of the
bone by immunohistochemical positivity for neuron-specific
enolase, synaptophysin, and chromogranin, and the
absence of staining for CD99, lymphoid markers, desmin,
myogenin, and myogenic differentiation 1. However, in our
case, that could not be ruled out.8
The prognosis of patients with a primary SmCC of the
head and neck is generally poor. Proportions of patients
surviving to 1 and 2 years were 63% and 26%.9 Overall,
primary SmCCs of the salivary glands have a better prog-
nosis than SmCCs found in other areas of the head and
neck, or lungs.10 The 2- and 5-year survival rates were re-
ported to be 70% and 46%, and 1- and 5-year survival rates
for submandibular glands were 71% and 40%, respectively.4
The paucity of SmCCs of the head and neck has led to
a lack of studies drawing major conclusions or providing
treatment recommendations. The combined modality
therapy of surgery, chemotherapy, and radiotherapy is used
for extrapulmonary SmCCs.10 Radical excision and adjuvantPlease cite this article in press as: Chen Y, et al., Primary small cell c
report and literature review, Journal of Dental Sciences (2012), http:chemotherapy using cisplatin (40 mg/body mass index) and
etoposide (130 mg/body mass index)11 seem to be good
options for SmCCs in the head and neck area. Treatments
fail because of regional recurrence and distant metastasis;
however, local recurrence is not frequently reported with
this disease.
Here, we reported a case of an extremely rare SmCC
occurring in the mandible. It had a better prognosis than
tumors in other extrapulmonary sites. Moreover, we
consider that surgical resection followed by chemotherapy
should be recommended for managing SmCCs in the
mandibular region.
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